Is Background Parenchymal Enhancement on Magnetic Resonance Imaging Helpful in Risk Assessment of Breast Cancer?


Maryam Farghadani 1 , * , Ali Hekmatnia 2 , Hoda Sharif 2 , Mehdi Baradaran 2 , Maryam Riahinezhad 3

1 Assistant Professor of MUI

2 Isfahan Medical University

3 Isfahan University of Medical Sciences

How to Cite: Farghadani M, Hekmatnia A, Sharif H, Baradaran M, Riahinezhad M. Is Background Parenchymal Enhancement on Magnetic Resonance Imaging Helpful in Risk Assessment of Breast Cancer?, Iran J Radiol. Online ahead of Print ; 14(Special Issue):e48039. doi: 10.5812/iranjradiol.48039.


Iranian Journal of Radiology: 14 (Special Issue); e48039
Published Online: April 12, 2017
Article Type: Abstract
Received: December 20, 2016
Accepted: February 7, 2017


Objectives: Background parenchymal enhancement (BPE) on contrast-enhanced magnetic resonance imaging (CE-MRI) corresponds to hormonally active breast fibroglandular tissue. Several have reported increased odds of breast cancer in patients with marked BPE. The purpose of the present study was to evaluate BPE in contralateral breast of biopsy proven breast cancer patients and comparison of the results with control group.

Methods: In a case-control study, CE-MRI of the contralateral breasts of 40 biopsy-proven breast cancer patients and 40 patients with biopsy- proven benign breast lesions, were retrospectively reviewed by an experienced radiologist and degree of BPE, and pattern of enhancement were determined, finally, BPE was compared between case and control groups using chi square test. Pearson correlation test was used to determine association between FGT amount and BPE. P value < 0.05 was considered significant.

Results: In the case group, 4, 17, 14, and 5 patients had minimal, mild, moderate, and marked BPE, respectively. In the control group, 12, 24, .and 4 participants had minimal, mild, and moderate BPE, respectively. BPE was significantly higher in the case group in comparison with the control group (P value < 0.05). Patients with invasive carcinoma had significantly higher BPE in comparison with the patients with carcinoma in situ. (P value < 0.05) There was a moderate correlation (r = 0.4, P value < 0.05) between FGT amount and degree of BPE. In the case group, 3, 26, and 11 patients had mass-non mass, mass, and non mass pattern of enhancement, respectively. In the control group, 25, antl15 participants had mass, and non mass pattern of enhancement, respectively. Pattern of enhancement was not significantly different between the two groups.

Conclusions: Our study revealed that patients with the diagnosis of breast cancer have greater BPE in comparison with control group. The results may be indicative for higher probability of developing breast cancer in patients with higher BPE. Therefore, CE-MRI could be a useful tool for breast cancer risk assessment.

Full Text

Full text is available in PDF

© 2017, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.